MKI67 and breast cancer: The researchers found that PVT1 is significantly overexpressed in breast cancer and can be used as an independent predictor of survival and prognosis.[16,17] The overexpression of PVT1 was significantly related to tumor size, pathological grade, Ki-67 positive rate and poor prognosis.